Metraipolis › archive › dc_f27e4c548afb

A recombinant rabies vaccine that prevents viral shedding in rabid common vampire bats (Desmodus rotundus) — Europe PMC PMID:36026522

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36026522
DOI
10.1371/journal.pntd.0010699
License (as archived)
CC0-1.0
Archived
2026-10-16T23:14:29.102Z
SHA-256 of the archived text
74845bc0a5b8ec6cbffc9c545d40871a17a7947c257b30ac2c1f178ff5ab07a4
Stable URL of this page
https://metraipolis.com/documento/dc_f27e4c548afb

How to cite

A recombinant rabies vaccine that prevents viral shedding in rabid common vampire bats (Desmodus rotundus) — Europe PMC PMID:36026522 — Europe PMC (en), https://europepmc.org/article/MED/36026522 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f27e4c548afb (Metraipolis archive dc_f27e4c548afb, sha256 74845bc0a5b8ec6cbffc9c545d40871a17a7947c257b30ac2c1f178ff5ab07a4)
BibTeX
@misc{dcf27e4c548afb,
  title = {A recombinant rabies vaccine that prevents viral shedding in rabid common vampire bats (Desmodus rotundus) — Europe PMC PMID:36026522},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36026522},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f27e4c548afb; sha256 74845bc0a5b8ec6cbffc9c545d40871a17a7947c257b30ac2c1f178ff5ab07a4},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36026522. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Vampire bat transmitted rabies (VBR) is a continuing burden to public health and agricultural sectors in Latin America, despite decades-long efforts to control the disease by culling bat populations. Culling has been shown to disperse bats, leading to an increased spread of rabies. Thus, non-lethal strategies to control VBR, such as vaccination, are desired. Here, we evaluated the safety and efficacy of a viral-vectored recombinant mosaic glycoprotein rabies vaccine candidate (RCN-MoG) in vampire bats (Desmodus rotundus) of unknown history of rabies exposure captured in México and transported to the United States. Vaccination with RCN-MoG was demonstrated to be safe, even in pregnant females, as no evidence of lesions or adverse effects were observed. We detected rabies neutralizing antibodies in 28% (8/29) of seronegative bats post-vaccination. Survival proportions of adult bats after rabies virus (RABV) challenge ranged from 55-100% and were not significantly different among treatments, pre- or post-vaccination serostatus, and route of vaccination, while eight pups (1-2.5 months of age) used as naïve controls all succumbed to challenge (P<0.0001). Importantly, we found that vaccination with RCN-MoG appeared to block viral shedding, even when infection proved lethal. Using real-time PCR, we did not detect RABV nucleic acid in the saliva samples of 9/10 vaccinated bats that succumbed to rabies after challenge (one was inconclusive). In contrast, RABV nucleic acid was detected in saliva samples from 71% of unvaccinated bats (10/14 sampled, plus one inconclusive) that died of the disease, including pups. Low seroconversion rates post-vaccination and high survival of non-vaccinated bats, perhaps due to earlier natural exposure, limited our conclusions regarding vaccine efficacy. However, our findings suggest a potential transmission-blocking effect of vaccination with RCN-MoG that could provide a promising strategy for controlling VBR in Latin America beyond longstanding culling programs.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2022 (prima pubblicazione 2022-08-26).
Identificativi: PMID 36026522 · PMCID PMC9455887 · DOI 10.1371/journal.pntd.0010699.
Descrittori MeSH principali: Chiroptera; Rabies virus; Rabies; Nucleic Acids; Rabies Vaccines.
Pagina: https://europepmc.org/article/MED/36026522 — https://doi.org/10.1371/journal.pntd.0010699. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-16T22:52:12.561Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.